Catecholestrogen Sulfation: Possible Role in Carcinogenesis
- 1 March 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 292 (2) , 402-408
- https://doi.org/10.1006/bbrc.2002.6658
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- METHYLATION PHARMACOGENETICS: Catechol O-Methyltransferase, Thiopurine Methyltransferase, and Histamine N-MethyltransferaseAnnual Review of Pharmacology and Toxicology, 1999
- Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiatorsProceedings of the National Academy of Sciences, 1997
- Molecular Mechanisms of Estrogen CarcinogenesisAnnual Review of Pharmacology and Toxicology, 1996
- p-Quinone methides are the major decomposition products of catechol estrogen o-quinonesCarcinogenesis: Integrative Cancer Research, 1996
- Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis.Proceedings of the National Academy of Sciences, 1995
- Conversion of estrone to 2- and 4-hydroxyestrone by hamster kidney and liver microsomes: implications for the mechanism of estrogen-induced carcinogenesisEndocrinology, 1994
- Mechanisms of Metabolic Activation and Inactivation of Catecholestrogens: A Basis of GenotoxicityPolycyclic Aromatic Compounds, 1994
- Human liver catechol-O-methyltransferase pharmacogeneticsClinical Pharmacology & Therapeutics, 1990
- Linkage relationships between a major gene for catechol‐o‐methyltransferase activity and 25 polymorphic marker systemsAmerican Journal of Medical Genetics, 1984
- Variations in catechol-O-methyltransferase activity in inbred strains of ratsNeuropharmacology, 1977